Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy

Caspofungin (CAS) which is used as salvage therapy in patients with invasive pulmonary aspergillosis (IPA) inhibits the 1,3-β-D-glucan synthesis in Aspergillus fumigatus. Inhibiting 1,3-β-D-glucan synthesis induces a stress response and in an invertebrate model it was demonstrated that inhibiting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Refos, Jeannine M., Vonk, Alieke G., ten Kate, Marian T., Eadie, Kimberly, Verbrugh, Henri A., Bakker-Woudenberg, Irma A. J. M., van de Sande, Wendy W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524388/
https://www.ncbi.nlm.nih.gov/pubmed/28742113
http://dx.doi.org/10.1371/journal.pone.0180961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524388/
https://www.ncbi.nlm.nih.gov/pubmed/28742113
http://dx.doi.org/10.1371/journal.pone.0180961

Ejemplares similares